Estrone

證據等級: L5

預測適應症: 2 個

Estrone: From Endogenous Estrogen to Zinc, Elevated Plasma

One-Sentence Summary

Estrone (雌酮) is an endogenous estrogen hormone with known roles in hormonal homeostasis, traditionally associated with hormone replacement therapy in menopausal conditions. The TxGNN model predicts it may be effective for managing Zinc, Elevated Plasma (hyperzincemia), with 0 clinical trials and 2 publications currently offering only indirect, mechanistic support for this direction.

Quick Overview

Item	Content
Original Indication	No approved indication data available (not marketed in Taiwan)
Predicted New Indication	Zinc, Elevated Plasma
TxGNN Prediction Score	99.81%
Evidence Level	L4
Taiwan Market Status	✗ Not Marketed
Number of Licenses	0
Recommended Decision	Hold

Why is This Prediction Reasonable?

Currently, detailed mechanism of action data is not available in this evidence pack. Based on known pharmacology, Estrone is an endogenous estrogen — one of the three primary estrogens naturally produced in the human body — and has been used clinically in hormone replacement contexts for menopausal conditions.

The mechanistic link proposed by the TxGNN model centres on estrogen’s known ability to upregulate metallothionein (MT) gene expression. Metallothioneins are cysteine-rich proteins that chelate zinc and other heavy metals in tissues; by increasing MT expression — particularly in the liver — estrone could theoretically enhance zinc sequestration and reduce circulating plasma zinc concentrations. Estrogen response elements (EREs) have been identified in MT gene promoter regions, making this pathway biologically plausible.

However, this mechanistic chain is indirect and inferential. No direct clinical evidence exists that estrone has been used to treat hyperzincemia. The two identified literature items touch on estrogen-zinc interactions in the contexts of protein-calorie malnutrition and perimenopausal metabolism, but neither directly validates estrone as a treatment for elevated plasma zinc. This prediction should be treated as hypothesis-generating only.

Clinical Trial Evidence

Currently no related clinical trials registered.

Literature Evidence

PMID	Year	Type	Journal	Key Findings
807594	1975	Observational/Cross-sectional	J Clin Endocrinol Metab	Studied the pituitary-gonadal axis in 28 men with severe protein-calorie malnutrition; testosterone and gonadal hormone changes observed during refeeding, providing indirect context on estrogen–mineral homeostasis relationships
12081830	2002	Interventional Study (dietary)	Am J Clin Nutr	Examined soy protein intake effects on iron indexes and total antioxidant status in perimenopausal women; notes that estrogen deficiency may increase metabolic and oxidative risk, tangentially relevant to estrogen–metal homeostasis

Safety Considerations

Please refer to the package insert for safety information.

Conclusion and Next Steps

Decision: Hold

Rationale: Although TxGNN assigns a high prediction score (99.81%), there are no clinical trials and zero direct studies supporting estrone as a treatment for elevated plasma zinc. Evidence consists solely of indirect mechanistic inference, warranting a Hold until foundational safety and mechanistic data gaps are resolved.

To proceed, the following is needed:

Retrieve MOA data from DrugBank (DB00655) to confirm or refute the estrogen → metallothionein → zinc sequestration pathway
Conduct a targeted literature search specifically on estrone/estrogen effects on plasma zinc levels or metallothionein regulation in human subjects
Download and parse the TFDA 仿單 (package insert) to address the Blocking data gap (DG001) on warnings and contraindications before any safety evaluation can proceed
Identify whether any preclinical (animal or in vitro) studies have directly tested estrone’s effect on zinc homeostasis
Assess route compatibility and clinically feasible dosing for this proposed indication
Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.